文献速递妇科产科

提高全球宫颈癌高级别治疗的可及性

Increasing global accessibility to high-level treatments for cervical cancers.
PubMed 文献 · Gynecol Oncol · 2021-10-27

本文讨论HPV相关妇科癌症在中低收入国家的主要健康负担,以及WHO 2020年宫颈癌消除目标中筛查与疫苗接种之外的治疗可及性问题。文章强调宫颈癌现代标准治疗为多模式综合治疗,需手术、外照射放疗(±化疗)和近距离放疗,并指出中低收入国家放疗/近距离放疗设施缺乏是主要障碍。提出通过外科导师制、配套培训项目和国际合作提升治疗质量,同时在高收入国家也需提高标准依从性。

要点

  • 宫颈癌标准治疗为手术、外照射放疗(±化疗)和近距离放疗的多模式综合治疗
  • 中低收入国家放疗/近距离放疗设施缺乏是提高治疗可及性的主要障碍
  • 需通过教育、培训、研究和技术合作加强国际支持并扩大现代系统治疗可及性

核心结论

  • 为宫颈癌患者提供最佳治疗是与筛查和疫苗接种互补的目标
  • 中低收入国家缺乏放疗/近距离放疗设施是主要关切
  • 需整合癌症照护和多学科方法以兼顾治愈率与生活质量

研究设计与样本

  • 本文为综述/观点性文章,讨论全球宫颈癌高级别治疗可及性策略,未报告系统检索范围或样本量

主要发现

  • 宫颈癌现代标准治疗复杂且为多模式,主要依赖手术、外照射放疗(±化疗)和近距离放疗
  • 中低收入国家放疗/近距离放疗设施缺乏是主要问题
  • 非循证治疗消耗资源、损害生活质量并影响肿瘤结局

关键数值与推荐

  • 2020年世界卫生组织启动宫颈癌消除项目,策略包括筛查和疫苗接种
  • 国际学会提供指导以定义最有效且毒性最低的抗癌策略、统一治疗方案并提供基准质量指标

临床怎么用

  • 应 upfront 提供适当的诊断检查和治疗,避免非循证治疗
  • 可应用外科导师制、配套培训项目和国际合作等策略提高治疗质量
  • 需加强国际支持包括教育、培训、研究和技术合作以扩大可及性
  • 在资源充足国家也应提高对标准的依从性
  • 应合理配置资源以避免有害的治疗延迟并确保转诊至专家中心

局限性

  • 本文未报告原始研究数据、样本量或统计比较
  • 未提供具体国家的设施缺口数据或干预效果量化结果

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Human papillomaviruses (HPV)-related gynecological cancers are a major health care issue, and a leading cause of cancer death in low- and middle-income countries (LMIC). In 2020, the World Health Organization launched a program aimed at cervical cancer elimination, by screening and vaccination strategies. Offering the best possible care to women diagnosed with invasive cancer is a complementary objective. Treatment of cervical cancer as per modern standards is complex and multimodal, mainly relying on surgery, external-beam radiotherapy (+/-chemotherapy) and brachytherapy. In parallel with the pivotal role of multidisciplinary discussion, international societies provide guidance to define the most effective and least toxic anti-cancer strategy, homogenize treatment protocols and provide benchmark quality indicators as a basis for accreditation processes. The challenge is to offer the appropriate diagnostic workup and treatment upfront and to avoid non- evidence-based treatment that consumes resources, impairs quality of life (QoL), and compromises oncological outcome. Various strategies may be applied for improving treatment quality: development of surgical mentorship, companion-training programs and international cooperation. The lack of radiotherapy/brachytherapy facilities is a major concern in LMIC. Reinforcing international support in terms of education, training, research and development and technical cooperation with national projects is required to increase access to minimum requirements but also introduce modern techniques, upgrade radiotherapy/brachytherapy services, and expand access to modern systemic treatments. In countries with robust economies, compliance to standards should also be increased. Integrative cancer care and multidisciplinary approaches are needed to tackle the dual challenge of increasing cure rates while minimizing QoL impairment. Appropriate dimensioning of the resources to avoid harmful treatment delays and access to expert referral centers is also a priority.

来源:Gynecol Oncol,查看原文。版权归原作者所有。

引用

  1. Chargari C, Arbyn M, Leary A, et al. Increasing global accessibility to high-level treatments for cervical cancers. Gynecol Oncol. 2021. PMID: 34716024. doi:10.1016/j.ygyno.2021.10.073

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。